VITALE, SILVIA RITA
 Distribuzione geografica
Continente #
NA - Nord America 1.071
EU - Europa 626
AS - Asia 494
AF - Africa 142
SA - Sud America 137
OC - Oceania 1
Totale 2.471
Nazione #
US - Stati Uniti d'America 1.055
IT - Italia 389
SG - Singapore 207
CN - Cina 145
BR - Brasile 126
CI - Costa d'Avorio 106
IE - Irlanda 81
IN - India 46
DE - Germania 33
KR - Corea 30
SN - Senegal 26
FI - Finlandia 24
GB - Regno Unito 24
RU - Federazione Russa 14
HK - Hong Kong 12
CA - Canada 10
TR - Turchia 10
CZ - Repubblica Ceca 8
PL - Polonia 8
UZ - Uzbekistan 8
VN - Vietnam 8
SE - Svezia 7
BE - Belgio 6
BD - Bangladesh 5
ES - Italia 5
IQ - Iraq 5
AR - Argentina 4
CH - Svizzera 4
FR - Francia 4
ID - Indonesia 4
MX - Messico 4
NG - Nigeria 4
NO - Norvegia 4
EC - Ecuador 3
IL - Israele 3
MA - Marocco 3
NL - Olanda 3
UA - Ucraina 3
GR - Grecia 2
JP - Giappone 2
LT - Lituania 2
OM - Oman 2
PE - Perù 2
AU - Australia 1
AZ - Azerbaigian 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EG - Egitto 1
HU - Ungheria 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
NP - Nepal 1
PK - Pakistan 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
ZA - Sudafrica 1
Totale 2.471
Città #
Santa Clara 198
Dallas 195
Chandler 150
Singapore 131
Catania 108
Abidjan 106
Chicago 98
Dublin 81
Hefei 49
Ashburn 42
Kochi 35
Boardman 29
Seoul 29
Los Angeles 28
Beijing 25
Dakar 25
Palermo 25
Civitanova Marche 23
Cambridge 20
Lawrence 20
Andover 16
Turku 15
Milan 14
Bari 13
Munich 12
New York 12
Hong Kong 10
The Dalles 10
Wilmington 10
Des Moines 9
Grafing 9
Rome 9
Santa Venerina 9
São Paulo 9
Brno 8
Columbus 8
Messina 8
Falls Church 7
Seattle 7
Aci Catena 6
Belo Horizonte 6
Brussels 6
Nanjing 6
Warsaw 6
Florence 5
Hanover 5
Lappeenranta 5
Pune 5
Saint Petersburg 5
San Giovanni la Punta 5
Tashkent 5
Abuja 4
Boston 4
Cesa 4
Comiso 4
Cosenza 4
Curitiba 4
Dong Ket 4
Fantina 4
Giardini-Naxos 4
Grammichele 4
Istanbul 4
Jakarta 4
London 4
Mascalucia 4
Modica 4
San Francisco 4
Verona 4
Bedford 3
Bremen 3
Council Bluffs 3
Edinburgh 3
Frankfurt am Main 3
Hanoi 3
Helsinki 3
Jinan 3
Manchester 3
Marília 3
Montreal 3
Nicolosi 3
Oslo 3
Rio de Janeiro 3
Rometta 3
Aci Sant'Antonio 2
Alessandria 2
Basra 2
Belém 2
Boydton 2
Brasília 2
Cabo Frio 2
Canoinhas 2
Casablanca 2
Cáceres 2
Duque de Caxias 2
Fairfield 2
Houston 2
Jiaxing 2
Madrid 2
Mandello del Lario 2
Mexico City 2
Totale 1.824
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 174
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 119
Mutational Analysis of BRCA1 and BRCA2 Genes in Breast Cancer Patients from Eastern Sicily 119
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 118
AKT Inhibitors: New Weapons in the Fight Against Breast Cancer? 106
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 100
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 99
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 99
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 99
An Optimized Workflow to Evaluate Estrogen Receptor Gene Mutations in Small Amounts of Cell-Free DNA 98
The prognostic and predictive value of ESR1 fusion gene transcripts in primary breast cancer 98
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 94
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 93
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 91
Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far 90
Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience 89
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 85
Opportunities and challenges of liquid biopsy in thyroid cancer 83
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma 83
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 80
Molecular Analysis of Luminal Androgen Receptor Reveals Activated Pathways and Potential Therapeutic Targets in Breast Cancer 72
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 70
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 68
Detection of tumor-derived extracellular vesicles in plasma from patients with solid cancer 66
In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients 57
PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance 55
Glucose-dependent effect of insulin receptor isoforms on tamoxifen antitumor activity in estrogen receptor-positive breast cancer cells 55
Single-Cell Analysis in the Omics Era: Technologies and Applications in Cancer 53
No Benefit from Hydroxyurea Pre-Treatment in Frontline Chronic Myeloid Leukemia Therapy and Evidence of Quantitative Changes in the BCR::ABL1 Transcript Level 33
Totale 2.546
Categoria #
all - tutte 9.654
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.654


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 6 21 4 0 1 10 1 0 5
2021/2022155 0 21 6 4 35 6 19 6 7 6 11 34
2022/2023465 26 40 24 55 21 67 9 82 93 10 24 14
2023/2024302 30 41 19 9 12 73 7 15 5 19 46 26
2024/2025958 13 137 36 79 175 135 77 22 35 65 128 56
2025/2026541 116 140 275 10 0 0 0 0 0 0 0 0
Totale 2.546